Joel Sunshine
banner
joelsunshine.bsky.social
Joel Sunshine
@joelsunshine.bsky.social
Biomedical Engineer, Dermatologist, Dermpathologist + Derm Residency Director @johnshopkins.bsky.social interested in medical and science education, gene delivery, immune engineering, and the tumor microenvironment
Reposted by Joel Sunshine
Here are the results in terms of the number of projects.

The number of funded projects in FY2025 is 4014 fewer than the number for FY2024.

2/3
September 29, 2025 at 5:38 PM
Reposted by Joel Sunshine
The fiscal year ends tomorrow.

Here are results from NIH Reporter downloaded an hour ago.

The total amount of funding committed for FY2025 at this point is 99.0% of that for FY2024. The same difference could be due to a variety of technical factors.

1/3
September 29, 2025 at 5:38 PM
Reposted by Joel Sunshine
New JCI paper from our group @pennmedicine.bsky.social on neutrophils in Sweet Syndrome:

www.jci.org/articles/vie...
August 27, 2025 at 10:14 AM
Reposted by Joel Sunshine
Vito Rebecca is part of "3D Spatial and in vivo Interrogation of the Vital Role of Stroma in Mortality in Acral Lentiginous Melanoma," led by Ashley Kiemen with @joelsunshine.bsky.social. 2/3
July 3, 2025 at 6:07 PM
Our collab with Ashley Kiemen and Vito Rebecca on "3D Spatial and in vivo Interrogation of the Vital Role of Stroma in Mortality in Acral Lentiginous Melanoma" was funded this year! Feel lucky to be at Hopkins and to get to do good science with these awesome people research.jhu.edu/major-initia...
June 19, 2025 at 7:18 PM
Reposted by Joel Sunshine
In these challenging times for our Hopkins researchers, any support can help keep their projects in the right direction.

With 39 Discovery awards ($150K) and 20 Catalyst awards ($100K), our office is providing such support for team science and early-career faculty.

hub.jhu.edu/2025/06/17/j...
June 19, 2025 at 3:33 PM
Excited that this work is out! "Siglec ligand immunohistochemistry reveals association with immune exclusion and survival" #glycotime www.laboratoryinvestigation.org/article/S002...
Siglec ligand immunohistochemistry reveals association with immune exclusion and survival
Sialic acids are overexpressed in many cancers, and binding of sialic acid via sialic acid binding immunoglobulin-like lectins (Siglecs) may contribute significantly to immune evasion and cancer progr...
www.laboratoryinvestigation.org
June 16, 2025 at 9:54 PM
Reposted by Joel Sunshine
Having a device that can measure TEWL remotely, continuously or as programmed by the investigator - and without perturbing a patient during sleep - is a major advance.

#wearabledevices #DermSky

A non-contact wearable device for monitoring epidermal molecular flux
www.nature.com/articles/s41...
April 11, 2025 at 1:12 PM
Reposted by Joel Sunshine
Add to this, the slow pace of new and competitive renewal awards due to study section and advisory council meeting delays and actual grant terminations, the flow of funds has been reduced and has become more unpredictable.

This is no effing way to run the world’s best biomedical research system.
a dog is looking at the camera with the words nope written below it
ALT: a dog is looking at the camera with the words nope written below it
media.tenor.com
March 17, 2025 at 7:32 PM
Reposted by Joel Sunshine
ICYMI, NIH will be asking soon for each NIH-funded researcher to justify every draw they make (often several times a week) on their grants and every NIH officer and their boss will have to justify their agreeing on these draws.

This is the death of US biomedical research by a thousand cuts
March 17, 2025 at 9:32 PM
Reposted by Joel Sunshine
5000 people could be lose their job at NIH very soon (25% of NIH workforce)
.
Positions in both intra and extramural programs are targeted.

Devastating self-harm to this country.

www.statnews.com/2025/03/14/n...
At NIH, ‘everyone is on edge’ as they brace for deep cuts and more centralized control
As the NIH braces for cuts of up to 5,000 of its 20,000 positions, “people are scrambling and freaking out,” a researcher said.
www.statnews.com
March 17, 2025 at 9:25 PM
Had a great time at AAD 2025. Particularly proud of our medical students and fellows who presented.
March 9, 2025 at 11:24 PM
If you are interested in the impact of the new gold and silver signals on the dermatology match process, check out our recent letter in the JAAD (doi.org/10.1016/j.ja...).
Redirecting
doi.org
March 6, 2025 at 9:29 PM
Reposted by Joel Sunshine
Top 10 ways American Science can survive the 15% indirect cap:

1. Breed special transgenic mice that can run for days in tiny hamster wheel turbines to keep lights on.

2. Get athletic program staff to donate 1% of their salaries to the research thus raising 100 billion dollars a year.
February 11, 2025 at 9:18 PM
Reposted by Joel Sunshine
This is the most relevant article to NIH and research cuts I’ve seen.

Imagine if this was today , how many people would be saying “Why are we studying Gila Monsters and their impact on diabetes ? That’s wasted money !”

globalnews.ca/news/9793403...
How a Canadian scientist and a venomous lizard helped pave the way for Ozempic - National | Globalnews.ca
In 1984, Dr. Daniel Drucker, an endocrinologist from the University of Toronto, discovered a hormone that helped pave the way for popular diabetes drugs such as Ozempic.
globalnews.ca
February 9, 2025 at 9:58 PM
Awesome paper from ex Hopkins MD PhD now at MSKCC and friend Karlo Perica demonstrating that Nef, an immune evasin from HIV, can reduce MHC expression and enhance allogeneic CAR-T fitness www.nature.com/articles/s41...
HIV immune evasin Nef enhances allogeneic CAR T cell potency - Nature
Nature - HIV immune evasin Nef enhances allogeneic CAR T cell potency
www.nature.com
February 2, 2025 at 10:20 PM
Wondering about best practices for mIF/mIHC image analysis and data sharing? See our @sitcancer.bsky.social SITC Taskforce Guidelines paper just published in JITC: jitc.bmj.com/content/13/1...
Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing
Objectives Multiplex immunohistochemistry and immunofluorescence (mIHC/IF) are emerging technologies that can be used to help define complex immunophenotypes in tissue, quantify immune cell subsets, a...
jitc.bmj.com
January 9, 2025 at 2:21 PM
Night #2 at Kīlauea Volcano. Spraying Lava from the central bright spot!
December 27, 2024 at 6:17 AM
So cool to be here at the Kilaeua volcano in Hawaii!
December 26, 2024 at 5:05 AM
Reposted by Joel Sunshine
Excited for the 2025 JH-TIE (jhtie.jhmi.edu) Immunoengineering Workshop! We have a phenomenal speaker lineup. Registration is free - sign up today!

jhtie.jhmi.edu/training-upc...
Johns Hopkins Translational ImmunoEngineering – Translational ImmunoEngineering
jhtie.jhmi.edu
December 11, 2024 at 1:48 AM
Reposted by Joel Sunshine
This was a period of time where taxpayer funded initiatives funded science at unprecedented rates.

These efforts made America a global social, economic, and educational powerhouse.

In 1966 at the peak of the Apollo program, we spent 2.5%GDP on science.

Now? Now we spend 0.6%GDP on science. 🧪
It still boggles my mind that only 66 years separate these photos.
December 22, 2024 at 3:27 PM
Reposted by Joel Sunshine
Check out the incredible DRESS (drug rxn w eosinophilia and systemic symptoms) review in @nejm.org by inpatient derm/society of derm hospitalists colleagues Drs Daniela Kroshinsky Rambi Cardones & amazing immunologist/drug rxn specialist Dr Kim Blumenthal

www.nejm.org/doi/full/10....
December 13, 2024 at 10:39 AM
Excited for the 2025 JH-TIE (jhtie.jhmi.edu) Immunoengineering Workshop! We have a phenomenal speaker lineup. Registration is free - sign up today!

jhtie.jhmi.edu/training-upc...
Johns Hopkins Translational ImmunoEngineering – Translational ImmunoEngineering
jhtie.jhmi.edu
December 11, 2024 at 1:48 AM